BCRX Past Earnings image   This BCRX past earnings page last updated 8/8/2022
BCRX Past Earnings
PeriodPast Earnings DateGAAP
Q2 20228/4/2022-0.320
Q1 20225/5/2022-0.400
Q4 20212/23/2022-0.400
Q3 202111/3/2021-0.330
Q2 20218/5/2021-0.240
Q1 20215/6/2021-0.360
Q4 20202/25/2021-0.340
Q3 202011/5/2020-0.260
Q2 20208/6/2020-0.240
Q1 20205/6/2020-0.240
Q4 20193/5/2020-0.020
Q3 201911/6/2019-0.340
Q2 20198/6/2019-0.340
Q1 20195/8/2019-0.280
Q4 20183/4/2019-0.25
Q3 201811/6/2018-0.28
Q2 20188/7/2018-0.19
Q1 20185/8/2018-0.26
Q4 20172/27/2018-0.2
Q3 201711/7/2017-0.18
Q2 20178/7/2017-0.21
Q1 20175/4/2017-0.19
Q4 20162/27/2017-0.06
Q3 201611/7/2016-0.16
Q2 20168/4/2016-0.22
Q1 20165/5/2016-0.31
Q4 20152/23/2016-0.25
Q3 201511/5/2015-0.2
Q2 20158/7/20150.06
Q1 20155/8/2015-0.21
Q4 20142/18/2015-0.16
Q3 201411/6/2014-0.12
Q2 20148/5/2014-0.23
Q1 20145/8/2014-0.17
Q4 20132/26/2014-0.09
Q3 201311/5/2013-0.14
Q2 20138/8/2013-0.23
Q1 20135/7/2013-0.09
Q4 20122/19/2013-0.22
Q3 201211/7/2012-0.19
Q2 20128/2/2012-0.25
BCRX Past Revenue
PeriodPast Earnings DateGAAP
Q2 20228/4/20220.07B
Q1 20225/5/20220.05B
Q4 20212/23/20220.05B
Q3 202111/3/20210.04B
Q2 20218/5/20210.05B
Q1 20215/6/20210.02B
Q4 20202/25/20210.00B
Q3 202011/5/20200.01B
Q2 20208/6/20200.00B
Q1 20205/6/20200.00B
Q4 20193/5/20200.04B
Q3 201911/6/20190.00B
Q2 20198/6/20190.00B
Q1 20195/8/20190.01B
Q4 20183/4/20192.73M
Q3 201811/6/20181.45M
Q2 20188/7/201812.49M
Q1 20185/8/20183.98M
Q4 20172/27/20183.89M
Q3 201711/7/20178.76M
Q2 20178/7/20173.10M
Q1 20175/4/20179.44M
Q4 20162/27/20178.98M
Q3 201611/7/20167.76M
Q2 20168/4/20164.79M
Q1 20165/5/20164.82M
Q4 20152/23/20164.60M
Q3 201511/5/201510.99M
Q2 20158/7/201525.84M
Q1 20155/8/20156.83M
Q4 20142/18/20155.45M
Q3 201411/6/20143.20M
Q2 20148/5/20141.47M
Q1 20145/8/20143.46M
Q4 20132/26/201410.60M
Q3 201311/5/20132.39M
Q2 20138/8/2013820000
Q1 20135/7/20133.55M
Q4 20122/19/20134.10M
Q3 201211/7/20125.76M
Q2 20128/2/20124.21M
Quotes delayed 20 minutes

Email EnvelopeFree BCRX Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold S&P 500 Stocks
10 Most Overbought S&P 500 Stocks
10 ETFs With Stocks Insiders Are Buying
10 ETFs With Most Upside To Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active S&P Call & Put Options
Biocryst Pharmaceuticals (BCRX) is categorized under the Healthcare sector; to help you further research past earnings across stocks, below are some other companies in the same sector:

BDSI Past Earnings
BDSX Past Earnings
BDTX Past Earnings
BDX Past Earnings
BEAM Past Earnings
BFLY Past Earnings
BHG Past Earnings
BIIB Past Earnings
BIO Past Earnings
BIOC Past Earnings

BCRX Past Earnings Q&A

What was the best and worst BCRX past earnings results?
For Biocryst Pharmaceuticals, I'm wondering what the company's very best and worst earnings results have been, on an earnings per share basis?

✔️Accepted answer: The highest BCRX past earnings result in our data set was 0.06/share posted in Q2 2015, while the lowest was in Q1 2022 when BCRX posted -0.400/share.

  Suggested answer: The biggest top line earnings performance — aka revenue — quarter was in Q2 2022 when BCRX reported 0.07B in revenue, while the quarter with the lowest revenue in our data set was Q2 2013 at 820000 of revenue.

  Suggested answer: There are 41 BCRX past earnings results in our data set.

On this page we presented the BCRX past earnings date information for Biocryst Pharmaceuticals. Reviewing that BCRX Past Earnings for the company, we see that the highest past earnings result in our data set was in Q2 2015, when BCRX posted gaap of 0.06/share. Meanwhile the lowest BCRX past earnings result was in Q1 2022, when BCRX posted gaap of -0.400/share. Turning to top line revenue performance, the biggest revenue quarter in our data set was seen in Q2 2022 when BCRX reported 0.07B in revenue, while the smallest revenue quarter was Q2 2013 when BCRX reported 820000 in revenue.

Any self directed investor doing their due diligence on BCRX or any other given stock can benefit from researching all of the Biocryst Pharmaceuticals past earnings — and here, we present each quarter's result all together on one page for easy comparison. Studying this information can help when projecting future earnings, as well as determining whether the past earnings trajectory justifies the current stock value. That's why we bring you PastEarnings.com to make it easy for investors to investigate Biocryst Pharmaceuticals past earnings, or the past earnings information for any stock in our coverage universe. And in your continued research we hope you will be sure to check out the further links included for earnings surprises history (beat/miss data) as well as next earnings dates for BCRX. Thanks for visiting, and the next time you need to research BCRX past earnings or those of another stock, we hope you'll think of our site, as your go-to past earnings research resource of choice.

Recommended: Institutional Holders of VIGI, FBMS Insider Buying, FCEL shares outstanding history.

 

BCRX Past Earnings | www.PastEarnings.com | Copyright © 2020 - 2022, All Rights Reserved

Nothing in PastEarnings.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.